---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-001164"
form_type: "8-K"
ticker: null
cik: "0001279695"
company_name: "UNIVERSAL BIOSENSORS INC"
filed_at: "2025-01-15T23:59:59+00:00"
generated_at: "2026-05-28T00:54:41.394712+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Universal Biosensors appoints CEO Sharman and CFO Mullin to board; grants 25M options subject to approval

## Summary
- Board expanded from 4 to 6 members; CEO John Sharman (Class II) and CFO Peter Mullin (Class I) appointed directors effective Jan 15, 2025.
- Sharman granted 10M options: 5M at A$0.20 (2-yr vest) and 5M at A$0.30 (3-yr vest), subject to shareholder approval at 2025 AGM.
- Mullin granted 15M options: 5M at A$0.15 (1-yr), 5M at A$0.20 (2-yr), 5M at A$0.30 (3-yr vest), also subject to shareholder approval.
- Neither Sharman nor Mullin receives compensation for board service; only expense reimbursements.
- Sharman and Mullin are not independent directors under SEC or Nasdaq rules.

## SEC filing metadata
- accession: 0001437749-25-001164
- form_type: 8-K
- cik: 0001279695
- company_name: UNIVERSAL BIOSENSORS INC
- filed_at: 2025-01-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1279695/000143774925001164/0001437749-25-001164-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1279695/000143774925001164/ubi20250114_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-001164
- JSON: https://secwatch.observer/filing/0001437749-25-001164.json
- Plain text: https://secwatch.observer/filing/0001437749-25-001164.txt

## Key facts
- Executive change
  John Sharman was appointed as Director at UNIVERSAL BIOSENSORS INC.
  - Action: appointed
  - Role: Director
  source text: On January 15, 2025, the board of directors (the “ Board ”) of Universal Biosensors, Inc. (the “ Company ”) increased the size of the Board from four to six members and appointed John Sharman, the Company’s Chief Executive Officer, and Peter Mullin, the Company’s Chief Financial Officer, to fill the newly created vacancy as Class II and Class I directors, respectively, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1279695/000143774925001164/0001437749-25-001164-index.htm
- Executive change
  Peter Mullin was appointed as Director at UNIVERSAL BIOSENSORS INC.
  - Action: appointed
  - Role: Director
  source text: On January 15, 2025, the board of directors (the “ Board ”) of Universal Biosensors, Inc. (the “ Company ”) increased the size of the Board from four to six members and appointed John Sharman, the Company’s Chief Executive Officer, and Peter Mullin, the Company’s Chief Financial Officer, to fill the newly created vacancy as Class II and Class I directors, respectively, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1279695/000143774925001164/0001437749-25-001164-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.